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The herpes simplex virus UL42 gene encodes a multifunctional polypeptide (UL42) that is essential for virus
DNA replication. To further understand the relationship between the structure of UL42 and the role that it
plays during virus replication, we analyzed an extensive set of mutant UL42 proteins for the ability to perform
the three major biochemical functions ascribed to the protein: binding to DNA, stably associating with the virus
DNA polymerase (Pol), and acting to increase the length of DNA chains synthesized by Pol. Selected mutants
were also assayed for their ability to complement the replication of a UL42 null virus. The results indicated that
the N-terminal 340 amino acids of UL42 were sufficient for all three biochemical activities and could also
support virus replication. Progressive C-terminal truncation resulted in the loss of detectable DNA-binding
activity before Pol binding, while several mutations near the N terminus of the polypeptide resulted in an
altered interaction with DNA but had no apparent affect on Pol binding. More dramatically, an insertion
mutation at residue 160 destroyed the ability to bind Pol but had no effect on DNA binding. This altered
polypeptide also failed to increase the length of DNA product synthesized by Pol, and the mutant gene could
not complement the growth of a UL42 null virus, indicating that the specific interaction between Pol and ULA2
is necessary for full Pol function and for virus replication. This study confirms the validity of the Pol-UL42
interaction as a target for the design of novel therapeutic agents.
Herpes simplex virus (HSV) provides an excellent model
system for the study of DNA replication in eukaryotic cells
in part because it encodes many if not all of the proteins that
are directly required for replication of the virus genome (6).
HSV is also a ubiquitous human pathogen whose control
relies primarily on antiviral drugs. The ultimate target of
most of these drugs is the virus-encoded DNA polymerase
(Pol), although in principle, any of the essential replication
proteins could serve as an excellent target (8).
The UL42 protein (product of the UL42 gene), another of
the essential replication proteins, was originally identified as
a double-stranded DNA (dsDNA)-binding protein (40). More
recently, it has become apparent that the virus Pol in fact
consists of a heterodimer of a catalytic subunit (product of
the UL30 gene) and UL42. As first described for HSV-2 (39,
44) and more recently for HSV-1 (11, 17, 20), the two
polypeptides copurify under a variety of conditions, indicat-
ing a stable association. Although the Pol polypeptide by
itself has catalytic activity (31), the processivity of the
enzyme on single-stranded templates is enhanced in the
presence of UL42 (20, 21). The UL42-binding site on Pol has
been mapped to the carboxy (C) terminus of the protein (13,
14), but little is known of the functional domains of UL42
itself or how it increases the processivity of Pol. The fact
that UL42 has an intrinsic affinity for dsDNA suggests the
attractive hypothesis that it tethers Pol to the template and
thereby increases processivity by discouraging dissociation
of the enzyme from the primer terminus (20). UL42 is
essential for viral DNA replication (23, 30), but it is not
known whether this derives from its role as a Pol accessory
subunit or whether it performs other functions.
* Corresponding author.
t Present address: NERC Unit, Stirling University, Stirling,
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In this report, we present the results of experiments
designed to map the regions of UL42 necessary for binding
to dsDNA and Pol by analysis of an extensive set of insertion
and deletion mutants. We then tested the ability of these
mutants to increase the length of DNA product synthesized
by Pol on a singly primed single-stranded DNA (ssDNA)
template. These results permitted a correlation between the
binding activities of the mutants and their ability to support
Pol-driven long-chain DNA synthesis and also allowed us to
make predictions regarding the organization of the domains
of the polypeptide. In addition, by correlating the results of
the in vitro assays with the ability of the mutants to comple-
ment the growth of a UL42 null mutant in transfected Vero
cells, we test the hypothesis that the Pol-UL42 interaction is
necessary for viral growth and is therefore a valid target for
the design of antiviral drugs.
MATERIALS AND METHODS
Linker insertion mutagenesis. A plasmid-encoded copy of
the KOS strain UL42 gene (pINGUL42 [14]) was pseudo-
randomly linearized by digestion with the frequently cutting
restriction enzyme HaeIII (New England Biolabs), ThaI
(Bethesda Research Laboratories), or AccII (Stratagene) in
the presence of ethidium bromide (38) and then linker tailed
with the 12-bp palindromic oligonucleotide TGCATCGAT
GCA as previously described (13). Unit-length plasmid was
gel purified and transformed into Eschenchia coli DH5ot,
following which colonies were screened for intact plasmids
containing a single insertion within the UL42 coding region
by standard miniprep and restriction enzyme digest. The
oligonucleotide was designed to include a ClaI restriction
enzyme site and not to encode proline or stop codons in any
translational reading frame. Insertions resulting in a mutant
phenotype, and those insertions which could not be unam-
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biguously located by restriction enzyme mapping, were
confirmed by dideoxynucleotide sequencing.
Deletion mutagenesis of UL42. The C-terminal deletion
mutants AC478, AC441, AC375, AC340, and AC307 (num-
bered according to the last UL42-specific residue present)
were obtained by linearizing plasmids containing the appro-
priate insertion mutant with ClaI to provide a truncated
template for in vitro transcription and subsequent translation
in rabbit reticulocyte lysate. AC269 was similarly expressed
by linearizing pING42 at a SalI site at nucleotide 1049 (33).
To obtain constructs capable of expressing the desired
C-terminal deletions after transfection into Vero cells, plas-
mids pING42(I-441), -(I-341), and -(I-308) were linearized as
described above and then linker tailed with the self-comple-
mentary oligonucleotide CGCTAGTCTAGACTAG, which
was designed to contain stop codons in all three translational
reading frames, as described previously (13). Plasmid
pING42A35-280 (numbers refer to the amino acids deleted)
was constructed by excising the central 750-bp PstI fragment
from the UL42 gene followed by religation of the remaining
plasmid. Plasmids pT742AN35AC282 and pT742AN281 (N-
terminal deletions are named according to the first UL42-
specific residue present) were constructed by cloning the
central 750-bp PstI fragment and a 3' 1,350-bp PstI fragment,
respectively, into the PstI site of plasmid pT7-7 (43). Plasmid
pT742AN10 was constructed by using the ClaI site of the
insertion mutant I-9 and an EcoRV site 3' to the UL42 gene
in the pING42 plasmid polylinker to excise all but the very 5'
end of the gene. After treatment with the Klenow fragment
of E. coli Pol I to generate blunt-ended DNA, the resulting
fragment was ligated into similarly blunt-ended EcoRI-cut
pT7-7. Similarly, plasmids encoding AN132 and AN160 were
constructed by using the end-filled ClaI sites of mutants
I-131 and I-160, respectively, except that a HindIlI site in the
polylinker was used to cleave the 3' end of the gene. The
insert for AN132 was ligated into pT7-7 cut with HindIII and
EcoRI (end filled), while AN160 was constructed with pT7-7
cut with SmaI and HindIII. In the latter five constructs, an
in-frame ATG is supplied by the vector. In-frame internal
deletions of UL42, i.e., A9-20, A20-131, A114-159, A131-
191, A161-223, A20-191, A242-250, A250-308, A308-356,
A191-250, A250-376, and A191-376, were all constructed in
a similar fashion. Constructs containing the appropriate
linker insertion mutations (Table 1) were digested with ClaI
and HindIII to divide the plasmids into a vector portion
containing that part of the UL42 gene 5' to the insertion and
a separate DNA fragment containing the 3' end of the gene
down to the unique HindIII site in the plasmid polylinker.
After agarose gel purification, vector and insert fragments
derived from plasmids containing linker insertions in the
same translational reading frame were ligated together to
generate the specified gene deletion. As these constructs
were derived from linker insertion mutants, each encodes a
four-amino-acid insertion as well as the indicated deletion.
In vitro transcription-translation and immunoprecipitation.
After linearization with the appropriate restriction enzyme,
plasmids were transcribed in vitro by either bacteriophage
SP6 or T7 RNA Pol, and the resulting mRNA was translated
in rabbit reticulocyte lysate (Promega) as previously de-
scribed (14). To assay the [35S]methionine-labeled UL42
mutants thus produced for the ability to bind to the HSV Pol,
the reticulocyte lysate was microcentrifuged for 10 min at
room temperature, and 5-pul aliquots of the supernatant were
then incubated with either 140 ng of 0-galactosidase (Sigma)
or 140 ng of purified HSV Pol (generous gift of K. Weisshart
of this laboratory). After an incubation of 1 h at room
TABLE 1. Locations and phenotypes of linker insertion
mutations in the UL42 gene
b ~~~~Phenotype'Insertiona Sequenceb
Pol binding DNA binding Processivity
1-9 A-VHRCT + + ++ ++
1-17 A-bVHRCT ++ ++* ++
1-20 A-bVHRCT + + ++* + +
1-113 ASMH ++ ++ ++
1-131 A-*VHRCT + + + + + +
1-160 ASMH - ++ -
1-191 A-VHRCT + + ++ + +
1-194 A-bVHRCT + + + + + +
I-224 ASMH + + + + + +
I-242 A-*VHRCT + + + + ++
1-250 A--VHRCT + + + + + +
1-308 A-bVHRCT + + + + + +
I-341 A-*VHRCT + + + + + +
1-356 A-VHRCT + + + + + +
I-376 A->HRCT + + + + + +
1-442 A-bVHRCT + + + + + +
I-478 ASMH + + + + + +
a Mutants are designated according to the codon number disrupted by the
linker insertion.
b The amino acids encoded by the inserted linker are given in standard
single-letter code. Also indicated where appropriate are the identities of amino
acids altered by out-of-reading-frame insertions.
I Scored as follows: + +, indistinguishable from wild-type UL42; -, no
detectable activity; + + *, the mutant bound DNA but displayed an altered salt
elution profile.
temperature, the aliquots were diluted by the addition of 100
,ul of immunoprecipitation buffer (IP buffer; 100 mM KCI, 50
mM Tris-CI [pH 7.6], 5 mM MgCl2, 1 mM phenylmethylsul-
fonyl fluoride, 0.02% NaN3) containing 0.1% Nonidet P-40
and 50 ,ul of a 10% (wt/vol) suspension of protein A-
Sepharose (Sigma) in the previous buffer. Finally, 2 ,ul of a
rabbit antiserum raised against a Pol-i-galactosidase fusion
protein capable of precipitating both Pol and P-galactosidase
(PP5 [47]) was added, and the mixture was incubated over-
night at 4°C on a rotator. The following day, the Sepharose
beads were collected by centrifugation and washed twice
with 750 ,ul of IP buffer containing 1% Triton X-100, 1%
sodium deoxycholate, and 0.1% sodium dodecyl sulfate
(SDS) and once with IP buffer containing 0.1% Nonidet P-40.
Bound proteins were then eluted by boiling in SDS-polyac-
rylamide gel electrophoresis (PAGE) sample buffer and
analyzed by SDS-PAGE and autoradiography.
DNA-cellulose chromatography. Aliquots of reticulocyte
lysate-expressed protein (10 p,l) were diluted into 100 p,l of
TM buffer (20 mM Tris-Cl [pH 7.6], 5 mM MgCl2) containing
50 mM NaCl, treated with 2 ,ul of an RNase A/T1 mixture
(RNace-it; Stratagene) for 20 min at room temperature to
remove free RNA, and then applied to a 0.5-ml-bed-volume
dsDNA-cellulose (Sigma) column equilibrated in the same
buffer. The column was washed twice with 0.5 ml of TM
buffer plus 50 mM NaCl and then sequentially eluted with 2
column volumes each of TM buffer containing 100 mM, 250
mM, 500 mM, and 1 M NaCl. The resulting 0.5-ml fractions
were then concentrated by ethanol precipitation in the
presence of 40 ,ug of carrier bovine serum albumin (BSA;
Sigma) and analyzed by SDS-PAGE.
Pol assays. Reticulocyte lysate-expressed ULA2 mutants
were assayed for the ability to increase the length of the
DNA products synthesized by purified HSV Pol on a singly
primed M13 ssDNA template. Aliquots of lysate were di-
luted in 50 ,ul of buffer containing 100 mM (NH4)2SO4, 20
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FIG. 1. Summary of UL42 deletion mutants. Expressed portions
of the UL42 ORF are represented as boxes, and deleted regions are
shown as lines. Phenotypes of the mutants in three in vitro assays
are tabulated on the right. Scores were assigned as follows; + +,
indistinguishable from wild-type UL42; +/-, weak activity; -,
minimal or undetectable activity; + + *, the mutant bound DNA but
displayed an altered salt elution profile. Overall phenotypes are also
indicated graphically by the shading of the boxes as follows: black,
mutants that behaved indistinguishably from wild-type UL42 in two
mM Tris-Cl (pH 7.5), 3 mM MgCl2, 0.1 mM EDTA, 0.5 mM
dithiothreitol, 4% glycerol, 40 ,ug of BSA per ml, 60 F.M
dATP, dGTP, and dGTP, 10 p.M [a-32P]dCTP (2 ,uCi), 25
fmol of purified Pol (generous gift of K. Weisshart), and 50
fmol of a singly primed M13 ssDNA template prepared as
described previously (13). After a 30-min incubation at 37°C,
10-pul samples were taken and analyzed by SDS-PAGE to
monitor the integrity of the mutant UL42 polypeptides,
while DNA synthesis was terminated in the remainder of the
reaction by the addition of 50 pul of 1% SDS-10 mM
EDTA-10 mM Tris-Cl (pH 8)-200 p.g of proteinase K per ml.
Following incubation at 37°C for 1 h, the samples were
extracted once with phenol-chloroform (1:1, vol/vol) and
ethanol precipitated, and the newly synthesized ssDNA was
detected by alkaline gel electrophoresis (29) and autoradiog-
raphy.
Transient complementation of a UL42 null mutant. Vero
cells at approximately 80% confluence were transfected with
100 ng of the indicated pING42 plasmids (which contain a
functional promoter) by the DEAE-dextran method. Sixteen
hours later, the cells were infected with the virus CgalA42 at
a multiplicity of infection of 3. CgalA42 has a 1.26-kb
deletion of the UL42 gene and is therefore phenotypically
null for UL42 (23; generously supplied by Paul Johnson and
Deborah Parris). After virus adsorption for 1.5 h, the cells
were washed twice with serum-free medium, treated for 2
min with an acid-glycine saline wash (5) to remove extracel-
lular virus, and then washed twice with serum-free medium,
after which fresh medium was added. Twenty-four hours
later, virus was harvested (9) and titered on the V9 cell line,
which contains a resident copy of the UL42 gene and is
therefore permissive for CgalA42 growth (23; generously
provided by Paul Johnson and Deborah Parris). Progeny
were also titered on Vero cells to ensure that they did not
arise from recombination events.
RESULTS
Insertion and deletion mutagenesis of UL42. To map the
regions of ULA2 important for its functions, we created a
library of 12-bp linker insertion mutations within the UL42
gene as described in Materials and Methods. Table 1 shows
the locations of the 17 mutants generated, numbered accord-
ing to the amino acid residue interrupted by the insertion. As
the inserted oligonucleotide contained a unique ClaI restric-
tion enzyme site, plasmids containing these mutations could
then be used to construct a series of N- and C-terminal
deletion mutants and a set of in-frame internal deletions
(Materials and Methods). Additional deletion mutants were
also constructed by using convenient restriction enzyme
sites within the UL42 gene. Figure 1 summarizes the sizes
and locations of the 24 deletion mutants examined in this
study.
Mapping the dsDNA-binding site of UL42. Since UL42 has
an intrinsic affinity for dsDNA, which may be of significance
for the protein's role as a processivity factor or other
functions, we assayed the panel of insertion and deletion
mutants described above for the ability to bind to a dsDNA-
cellulose column. Aliquots of the [35S]methionine-labeled
polypeptides were diluted at least 10-fold in buffer containing
or more assays; grey, mutants that had some activity in one assay;
and white, those that had minimal or undetectable activity in all
three assays. aa, amino acids.
p3
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FIG. 2. DNA-binding assay. [35S]methionine-labeled UL42 poly-
peptides expressed in rabbit reticulocyte lysate were applied to
DNA-cellulose columns and eluted with buffer containing the indi-
cated concentration of NaCl. Fractions were collected and analyzed
for protein content by SDS-PAGE and autoradiography. An equiv-
alent unfractionated amount of each sample was also analyzed
(Total). WT, wild-type.
50 mM NaCl and applied to a DNA-cellulose column before
stepwise elution with 2 column volumes each of buffer
containing salt at the concentrations shown in Fig. 2. Frac-
tions of 1 column volume each were collected and analyzed
by gel electrophoresis after concentration by ethanol precip-
itation. Wild-type UL42 synthesized in rabbit reticulocyte
lysate was retained by the column, with very little protein
appearing in the wash fractions (50 mM). The bound
polypeptide was eluted by increasing salt concentrations,
with the majority of the material appearing in the 250 mM
fractions (Fig. 2A). Control experiments using cellulose
alone as a column matrix revealed no significant retention of
the polypeptide (data not shown), indicating that the assay
reflects a genuine interaction with DNA. Two C-terminal
deletion mutants (AC375 and AC340) behaved like full-length
UL42 in that the majority of the protein was retained by the
column at 50 mM NaCl but then eluted in the presence of 250
mM NaCl (Fig. 2B and C). However, further C-terminal
truncation (AC307; Fig. 2D) resulted in a polypeptide that
eluted almost entirely in the first wash fraction, indicating
that in 50 mM NaCl, it had very little affinity for DNA.
The smallest N-terminal truncation tested (AN10) dis-
played an altered ability to bind DNA (Fig. 2E). Like
wild-type UL42, most of the polypeptide was retained by the
column at 50 mM NaCl, but instead of the majority eluting at
250 mM NaCL, approximately half of the material was eluted
by 1 M NaCl. AN10 was not retained by a cellulose column
(data not shown), indicating that the altered elution profile
from dsDNA-cellulose results from an altered interaction
with DNA. Mutants AN132 and AN160 eluted almost en-
tirely in the wash fractions, indicating the loss of DNA-
binding activity (Fig. 1), but unexpectedly, further trunca-
tion of the N terminus of the polypeptide apparently restored
DNA binding, as mutant AN281 was retained by the column
at 50 mM NaCl but eluted with 500 mM salt (Fig. 2F).
Additionally, AN281 did not bind to a cellulose column (45).
We also tested 13 internal deletion mutants that removed
in sum residues 9 to 376 for the ability to bind DNA. Eleven
of these mutants were not retained significantly by the
column at 50 mM NaCl (Fig. 2G [A20-131] and H [A161-
223]; results for other mutants are summarized in Fig. 1).
However, a small deletion near the middle of the polypep-
tide, A242-250, apparently did not affect DNA binding, as
the polypeptide eluted normally at 250 mM salt (Fig. 1).
Interestingly, a mutant containing a small deletion near the
N terminus, A9-20, behaved similarly to AN10 in that it
eluted in two populations, one at 250 mM and one at 1 M
NaCl (Fig. 1).
The panel of 17 linker insertion mutants was also assayed
for DNA-binding ability. As shown for I-160 (Fig. 2I), 15 of
the insertion mutants bound DNA normally and eluted with
250 mM NaCl (summarized in Table 1). However, two
insertion mutations near the N terminus (1-20 [Fig. 2J] and
1-17 [Fig. 1]) eluted partially at 250 mM and partially at 1 M
salt, similarly to the N-terminal deletion mutants AN10 and
A9-20.
The results of these experiments are summarized in Fig. 1
and Table 1; the N-terminal two-thirds of the polypeptide is
sufficient for DNA binding, while the C-terminal 148 amino
acids are dispensable. Consistent with this finding, all of the
deletion mutants assayed that lacked more than 12 residues
from within these N-terminal 340 amino acids failed to bind
DNA, with the notable exception of AN281, while mutations
within the first 20 amino acids altered the interaction with
DNA.
Mapping the Pol-binding site on UL42. Next, we attempted
to map the region of UL42 responsible for binding to Pol by
analyzing the ability of various deletion mutants to copre-
cipitate with Pol. Figure 3a shows the results obtained with
wild-type and mutant UL42 polypeptides lacking 113, 148,
and 219 residues from the C terminus of the protein. [35S]me-
thionine-labeled wild-type UL42 synthesized in rabbit
reticulocyte lysate was immunoprecipitated by antisera di-
rected against a Pol-,B-galactosidase fusion protein when
mixed with unlabeled purified Pol but not when incubated
with I-galactosidase (Fig. 3aA). This specific coprecipitation
is indicative of a stable complex formed between the two
polypeptides. Truncated UL42 proteins lacking as many as
148 amino acids from the C terminus (AC375 and AC340)
similarly coprecipitated with Pol but not with 1-galactosi-
dase (Fig. 3aB and C). Consistent with this finding, mutants
containing smaller deletions of the C terminus (AC478 and
AC441) also bound Pol normally (Fig. 1). However, further
deletion of C-terminal sequences resulted in polypeptides
that coprecipitated with Pol to a substantially reduced extent
and also displayed some nonspecific precipitation with ,3-gal-
actosidase (AC269 [Fig. 3aD] and AC307 [Fig. 1]).
Figure 3b shows the results of similar experiments carried
out on UL42 mutants containing progressive deletions of the
N terminus. The loss of nine residues from the N terminus of
the polypeptide (AN10) did not prevent the altered UL42
protein from coprecipitating with Pol (Fig. 3bA). Larger
deletions of the N terminus such as AN132 or AN281
J. VIROL.
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FIG. 3. Ability of N- and C-terminally truncated UL42 mutants
to bind Pol. Aliquots of the indicated [35S]methionine-labeled UL42
polypeptides expressed in rabbit reticulocyte lysate were analyzed
by SDS-PAGE before (T) or after immunoprecipitation with antisera
reactive against Pol and 3-galactosidase in the presence of 3-galac-
tosidase (-) or Pol (+). Migration of the UL42 proteins is indicated
by arrowheads. (a) C-terminal deletion mutants; (b) N-terminal and
both N-terminal and C-terminal deletion mutants. WT, wild type.
destroyed this specific interaction, as the radiolabeled UL42
polypeptide was not significantly immunoprecipitated in the
presence of Pol (Fig. 3bB and C). Indeed, larger quantities
could be precipitated in the presence of 3-galactosidase. A
UL42 mutant truncated at both the N and C termini
(AN35AC282) was weakly coprecipitated by the anti-Pol
serum, indicating that it retained some Pol-binding ability
(Fig. 3bD).
The results of these experiments suggested that the Pol-
binding site of UL42 was situated between residues 10 and
340, with some activity residing upstream of amino acid 269.
Therefore, we next tested the effects of the set of in-frame
internal deletions. Figure 4 shows the results obtained with
five of these mutants. In general, most internal deletions of
UL42 resulted in the loss of Pol-binding ability, as shown by
the lack of significant coprecipitation of mutants A20-131
(Fig. 4A), A161-223 (Fig. 4B), A250-308 (Fig. 4D), and
A308-356 (Fig. 4E) by the anti-Pol-I-galactosidase sera. A
variety of other internal deletions summarized in Fig. 1 were
assayed for heterodimerization but also resulted in polypep-
tides unable to bind Pol. However, the two smallest dele-
tions tested, A9-20 (Fig. 1) and A242-250 (Fig. 4C), retained
the ability to form a stable complex with Pol, much as they
retained the ability to bind DNA.
We also examined the effects of 17 separate four-amino-
acid insertions on heterodimerization. Sixteen of the linker
insertions bound Pol with wild-type efficiency (Fig. 4F
[I-131] and H [1-250]; Table 1). However, the insertion
mutant I-160 was not precipitated by the anti-Pol sera in the
presence of Pol, indicating that it could no longer form a
stable complex with Pol (Fig. 4G). The results of these
experiments are summarized in Fig. 1 and Table 1.
E F G H
FIG. 4. Ability of ULA2 mutants containing in-frame internal
deletions or linker insertion mutations to bind Pol. The indicated
UL42 mutants were tested for their Pol-binding activity as described
in the legend to Fig. 3. The samples in panel H were electrophoresed
on a higher-percentage gel than were the others.
Ability of selected UL42 mutants to increase the length of
DNA product synthesized by Pol. UL42 has been shown to
enhance synthesis of longer DNA products from a uniquely
primed ssDNA template by Pol through an increase in
processivity (20). Therefore, we tested the ability of our
panel of UL42 mutants to increase the size of DNA product
synthesized by Pol from a singly primed M13 ssDNA tem-
plate. Aliquots of each mutant synthesized in rabbit reticu-
locyte lysate were incubated with 50 fmol of the primed
template and 25 fmol of Pol purified from a baculovirus
overexpression system in the presence of all four deoxynu-
cleoside triphosphates (dNTPs), including [a-32P]dCTP.
Newly synthesized ssDNA was then detected by autoradiog-
raphy after fractionation on an alkaline agarose gel. This
approach is similar to that of Gallo and coworkers (16), in
which cell-free translated UL42 was used to stimulate Pol
activity on an activated DNA template. However, our assay
uses purified Pol and a template that more directly reflects
the processivity of DNA synthesis. Figure 5 shows the
results obtained with wild-type and five mutant UL42 poly-
peptides. Purified Pol synthesized only short lengths ofDNA
when incubated with water-programmed reticulocyte lysate
(Fig. 5A, lanes n, o, and v; the small amount of material
migrating slightly faster than full-length M13 in lane v results
from incomplete denaturation of elongated primer-template
duplex), whereas reticulocyte lysate alone had no detectable
Pol activity (lane m). However, as increasing amounts of
wild-type UL42-programmed reticulocyte lysate was added
to purified Pol, synthesis of small DNA products was re-
duced and replaced by production of substantially longer
strands, including some full-length M13 (lanes a to c).
Therefore, in vitro-expressed UL42 appears to increase the
processivity of purified Pol. Similarly, deletion mutants
AN10 (lanes d to f) and AC340 (lanes j to 1) and insertion
mutant I-131 (lanes p to r) also increased Pol-mediated
a
b
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FIG. 5. Ability of UL42 mutants to increase the length of the DNA strand synthesized by Pol. Aliquots of rabbit reticulocyte lysate
programmed with water (blank) or with mRNA encoding the indicated UL42 polypeptides were incubated with 25 fmol of purified Pol [except
for lane m (-), in which Pol was omitted], 50 fmol of a singly primed M13 ssDNA template, and all four dNTPs, including [cx-32P]dCTP, as
described in Materials and Methods; 1-, 2.5-, and 5-,ul aliquots of lysates expressing UL42 polypeptides were used; while the samples run in
lanes m, o, and v contained 5 ,u1 of blank lysate, and the sample in lane n contained 1 ,ul. (A) Samples were analyzed for their content of[ax-32P]dCTP-labeled DNA by electrophoresis on a 1.3% alkaline agarose gel after proteinase K digestion. Migration of full-length replicated
M13 is indicated by the arrowhead. (B) Samples were analyzed for their content of [35S]methionine-labeled protein by autoradiography after
SDS-PAGE. WT, wild type.
synthesis of longer DNA strands while decreasing the
amount of short products. In contrast, addition of deletion
mutant AC307 (lanes g to i) or insertion mutant 1-160 (lanes
s to u) did not increase the length of DNA synthesized by
Pol. To rule out the possibility that this defect resulted from
instability or underexpression of the polypeptides, we ana-
lyzed aliquots of the Pol assays after the reaction period by
SDS-PAGE for the presence of the [35S]methionine-labeled
UL42 mutants. As shown in Fig. 5B, the AC307 and 1-160
polypeptides were present in amounts similar to those of
mutants which were able to mediate synthesis of longer
DNA products.
We also tested the other UL42 mutants for the ability to
increase the length of DNA polymerization product synthe-
sized by Pol. We found that the 13 insertion and 5 deletion
mutants that were unaffected for both Pol and DNA binding
also functioned normally to increase the length of DNA
product synthesized by Pol (Fig. 1; Table 1). Interestingly,
insertion mutants 1-17 and 1-20 and the deletion mutants
/N10 and A9-20, which showed an altered interaction with
DNA, also behaved like wild-type UL42 (Fig. 5, lanes d to f;
Fig. 1; Table 1). The 14 deletion mutants that bound Pol and
DNA weakly or negligibly did not affect the polymerization
activity of Pol (Fig. 1). These results are consistent with but
substantially extend those of Gallo and coworkers (16), who
found that a UL42 mutant lacking 28 residues from the C
terminus could still stimulate Pol activity, while one trun-
cated at amino acid 249 and one equivalent to our A35-280
could not.
Transient complementation of a UL42 null mutant. To
assess the effect of the UL42 mutations on virus replication
in vivo, we tested the ability of selected plasmids containing
mutant UL42 genes to complement the replication of virus
CgalA42. CgalA42 contains a large deletion within the UL42
coding region and therefore cannot replicate in the absence
of an exogenously supplied source of UL42 (23). Accord-
ingly, Vero cells were transfected with the UL42-encoding
plasmids and then superinfected with CgalA42. Any resulting
virus progeny were then harvested and titered on the cell line
V9, which contains a resident copy of the UL42 gene and is
therefore permissive for the growth of CgalA42. Table 2
shows the results obtained with a subset of the UL42
mutants. Insertion mutant I-131 and the two carboxy-termi-
nal deletion mutants AC441 and AC340, which all bound Pol
and DNA normally and increased the length ofDNA product
polymerized by Pol, substantially complemented the growth
of CgalA42. However, mutant I-160, which was able to bind
DNA but unable to bind Pol or to function as a processivity
factor, failed to complement replication of the UL42 null
mutant. Deletion mutant AC307, which bound Pol weakly
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TABLE 2. Ability of selected UL42 mutants to complement a
UL42 null mutant
Genie % Comple-mentationa
AC441 ......................................... 51
AC340 ......................................... 35
AC307 ......... ................................ 0.04
AN160 ......... ................................ 0.2
A114-159 ........... .............................. 0.02
I-131 ......................................... 61
I-160 ......................................... 0.2
No plasmid ......................................... 0.0013
a Percentage relative to the complementation seen with the wild-type gene.
All results are averages of at least two independent experiments. Figures in
italics are considered to represent substantially lower than wild-type comple-
mentation.
but was unable to bind DNA or to function as a processivity
factor, also failed to complement replication of the null
mutant, as did the mutants AN160 and A114-159, which were
impaired in all three in vitro assays.
DISCUSSION
The DNA-binding domain of UL42. In the assay for DNA
binding used in this study, wild-type UL42 synthesized in
rabbit reticulocyte lysate bound to dsDNA-cellulose in 50
mM NaCl and was eluted predominantly by 250 mM NaCl.
Other studies have reported elution of UL42 from DNA-
cellulose columns only at higher concentrations of NaCl
(32). However, this discrepancy most likely reflects the
stepped elution gradient used here, as UL42 purified from a
baculovirus overexpression vector eluted similarly to the
cell-free translated UL42 in this assay but at higher salt
concentrations when a continuous gradient was used (45).
C-terminal truncation of UL42 indicated that the C-termi-
nal one-third of the polypeptide was not necessary for
dsDNA binding, as mutant AC340 eluted from a dsDNA-
cellulose column indistinguishably from wild-type UL42.
Further truncation of the C terminus, as in mutant AC307,
destroyed the ability of the polypeptide to bind DNA,
suggesting that residues between amino acids 308 and 340
play at least an indirect role in nucleic acid contact. In
contrast to the relative insensitivity of the C terminus to
truncation, the N-terminal insertion mutations I-17 and 1-20
and the deletion mutations AN10 and A9-20 all affected
DNA binding. All four mutants showed a biphasic fraction-
ation profile from the dsDNA-cellulose column, with one
population of material eluting normally at 250 mM and one
eluting at 1 M NaCl. This finding suggests that this region of
the polypeptide affects DNA-binding properties. However,
mutant AN281 was also retained by the dsDNA-cellulose
column and eluted predominantly at 500 mM NaCl. This
finding is consistent with the importance of residues up-
stream of amino acid 340 inferred from the analysis of
C-terminally truncated polypeptides but surprising in view of
the cluster of N-terminal mutations that affected interaction
with DNA, and also because the larger C-terminal fragments
AN132 and AN160 and several internal deletion mutants
retaining residues 281 to 448 lacked significant DNA-binding
ability. The behavior of the latter mutants could result from
malfolding of the polypeptide induced by the extra upstream
sequences. The central regions of UL42 also appeared
important for DNA binding, as all internal deletions tested
except the small deletion A242-250 failed to bind DNA.
However, since these mutants also failed to bind Pol, as
suggested above, they may be malfolded polypeptides and
therefore provide little information on the direct function of
the deleted residues.
One possible interpretation of the results presented above
is that UL42 contains two regions that influence DNA
binding: one site downstream of amino acid 281 that in some
sequence contexts is sufficient to bind DNA alone, and a site
closer to the N terminus that includes but is not limited to the
first 20 residues that may contact DNA as well or otherwise
modulate the activity of the C-terminal region indirectly. In
this respect, it is interesting that AN281 eluted from DNA at
a higher NaCl concentration than did full-length UL42, while
several N-terminal mutations also showed a partial increase
in salt resistance. This interpretation requires that in the
cases in which sequences outside of amino acids 281 to 340
were deleted with loss of DNA-binding function, the mutant
polypeptide was incorrectly folded. The fact that in every
such instance Pol binding was also lost is consistent with this
proposal, but further analysis is necessary to test the validity
of this hypothesis. It is also interesting to note that the
N-terminal one-quarter of UL42 contains a region of weak
sequence similarity with the DPS polypeptide, a dsDNA-
binding protein from E. coli (1).
The Pol-binding domain of UL42. The analysis of UL42
deletion mutants suggests that the Pol-binding site is con-
tained between residues 21 and 340, since separate removal
of the first 20 and last 148 residues of the polypeptide did not
affect complex formation. Additional removal of C-terminal
sequences in mutants AC307, AN35AC282, and AC269 re-
duced heterodimer formation but did not totally destroy it,
implying that at least part of the Pol-binding site lies up-
stream of amino acid 269. Interestingly, these three mutants
had little or no detectable DNA-binding activity, suggesting
that the two activities are separable, although it is difficult to
gauge the sensitivities of the assays used. Consistent with an
N-terminal Pol-binding domain, most internal deletions
within the N-terminal 350 residues prevented heterodimer-
ization, and the only 1 of 17 four-amino-acid-insertion mu-
tations to affect Pol association was at position 160. 1-160
bound DNA normally, indicating that its inability to form a
stable complex with Pol did not result from global malfold-
ing. This result also confirms that the activities of DNA and
Pol binding are separable. It is premature to conclude that
the I-160 mutation lies directly within the protein-protein
contact site, but as shown in Fig. 6, I-160 does fall within a
highly hydrophilic stretch of amino acids and may therefore
be a plausible candidate for a solvent-exposed binding site.
The UL42-binding site on Pol has been characterized in
some detail. Previous work showed that the C-terminal 227
amino acids of Pol are sufficient to bind UL42 (14), and a
more recent study has demonstrated that the final 35 amino
acids of Pol are crucial for complex formation (13). This
region of Pol contains a 3, -4 hydrophobic repeat and is
predicted to be predominantly at helical by the Robson-
Garnier secondary-structure prediction algorithm (13, 18).
This finding raised the possibility that Pol and UL42 het-
erodimerize by a coiled-coil hydrophobic interaction, similar
to that seen in many fibrous proteins and the leucine zipper
class of transcriptional activators (10, 27, 37). The best
candidate for a matching amphipathic ox-helical region in
UL42 lies between residues 242 and 253 (there are other
regions of UL42 that contain a 3, -4 repeat of hydrophobic
amino acids but which are not predicted to be ao helical by
Robson-Garnier analysis). However, as shown in Fig. 3, the
major portion of this area was deleted in the mutant A242-
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FIG. 6. Hydrophilicity plot of UL42. The predicted sequence of HSV strain 17 UL42 was analyzed for hydrophilicity, using the
Hopp-Woods algorithm and a window size of 17 residues. Thick vertical bars indicate the extent of N- and C-terminal truncations that were
tolerated without loss of protein activity.
250 without affecting Pol binding. Therefore, we do not
currently favor the coiled-coil model of interaction. Interest-
ingly, the hydrophilic region around amino acid 160 (residues
148 to 163) is strongly predicted to be (x helical, raising the
possibility of a more novel polar or charged interaction
between two helices.
Possible structure of UL42. In the absence of truly accurate
methods of predicting protein conformation, some predic-
tions can nevertheless be made from cautious sequence
analysis interpreted in the light of experimental data. For
example, hydrophilic stretches of residues may function as
linker regions between independently folded domains of a
polypeptide or may be surface exposed loops on one domain
(41). The results of genetic, biophysical, and biochemical
experiments can be used to decide between these alterna-
tives. Figure 6 shows a hydrophilicity plot for strain 17 UL42
(33) generated by using the Hopp-Woods algorithm (22),
which predicts that the polypeptide has hydrophilic stretches
at both the N and C termini and, internally, centered around
amino acid 155. The vertical bars indicate the extent of N-
and C-terminal deletions that were tolerated without loss of
DNA- or Pol-binding function and also show a close corre-
lation with the hydrophilic terminal regions.
The hydrophilic region around amino acid 155 could
potentially indicate a boundary between N-terminal and
central domains of the protein. However, we prefer to
interpret it as a surface-exposed region on a single domain,
since a variety of deletion mutants lacking sequences either
N or C terminal to amino acid 155 were globally defective in
the assays used in this study. The fact that the only linker
insertion mutation to affect Pol binding (but not DNA
binding) lay within this hydrophilic stretch also supports this
hypothesis. Therefore, we propose that UL42 consists of an
N-terminal domain composed approximately of the first 308
to 340 amino acids and a C-terminal region including the final
148 residues. The N-terminal domain includes both Pol- and
DNA-binding functions, is sufficient to increase the apparent
processivity of the Pol subunit, and can also complement
replication of a UL42 null mutant. This region of UL42 is
also the most highly conserved in open reading frame (ORF)
16, encoding the corresponding varicella-zoster virus protein
(12). The C terminus of UL42 is not required for any of the
assayed functions in vitro and also seems to be nonessential
for replication in tissue culture. It is also highly hydrophilic
(Fig. 6) and rich in proline residues, so it may not fold
compactly in the true sense of a domain. The results of
partial proteolytic digestion experiments are consistent with
the predictions presented above, since the major stable
proteolytic fragments generated by a variety of proteases
arose from the N-terminal two-thirds of UL42, while no
stable fragments including the C terminus of the protein were
observed (26). Although the proposed N-terminal domain
envelops Pol- and DNA-binding activities, the two functions
are clearly separable, since an insertion mutation at position
160 destroyed heterodimerization without affecting DNA
binding. Similarly, several mutations at the N terminus
altered DNA binding but not complex formation, and pro-
gressive truncation of the C terminus abrogated DNA bind-
ing before Pol binding in our assays.
Mechanism of UL42 as a processivity factor. Previous
studies have shown that Pol synthesizes longer DNA prod-
ucts in the presence of UL42 (20, 21) and that this activity
results from an increase in processivity (20). Therefore, it
seemed likely that this activity resulted from a specific
interaction between the two polypeptides, although some
workers have reported stimulation of HSV Pol by unrelated
DNA-binding proteins (35). The failure of mutant I-160 to
increase the size ofDNA products synthesized by Pol argues
that the UL42-mediated increase in processivity directly
requires the Pol-UL42 interaction, since I-160 bound DNA
normally but did not bind Pol. In addition, the failure of I-160
to complement growth of a virus lacking a functional copy of
the UL42 gene confirms that the Pol-UL42 interaction is
necessary for virus replication. This result is consistent with
the observed phenotypes of Pol mutants unable to bind
UL42 (13) and therefore validates the Pol-UL42 interaction
as a target for directed drug design (14).
We generated three mutants that retained a low level of
Pol-binding activity but had minimal DNA-binding ability
(AC307, AN35AC282, and AC269). None of these mutants
were able to increase the apparent processivity of Pol, but
they do not conclusively test the hypothesis that UL42
increases the processivity of Pol by tethering it to the DNA
template (20), as their marked reduction in Pol binding could
also have caused the defect. However, all of the mutants
which associated with both Pol and DNA also increased the
length of DNA synthesized by Pol, which is consistent with
but does not prove the idea that Pol binding and DNA
binding are sufficient for function as a processivity factor.
If UL42 does increase the processivity of Pol through its
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own DNA-binding activity, then it is interesting to note that
this implies a different mode of action to the best-character-
ized Pol processivity factor, the1B subunit of E. coli Pol III
(Pol III-\). PolIII-,B has no intrinsic affinity for DNA (42) but
rather dimerizes to form a torus that is sterically retained on
the nucleic acid strand (24). The DNA-binding model for
UL42 as a processivity factor also raises the problem of how
the protein slides to follow the elongating primer without
acting as a brake on Pol.
Other known processivity factors include the gene 45
protein of bacteriophage T4 and the proliferating cell nuclear
antigen of eukaryotic Pol 8, but similarly to PolIII-,B, gene 45
and proliferating cell nuclear antigen have little affinity for
DNA (3, 25, 28, 34); in fact, an analogous structure has been
proposed for the three polypeptides (24). However, as
eukaryotic Pol 8 is also a heterodimer of =125- and 50-kDa
subunits (4), possibly a better cellular analog or homolog for
UL42 may be the as yet uncharacterized 50-kDa subunit.
Does ULA2 play a role other than as a processivity factor? In
the course of a normal productive HSV infection, Pol
expression peaks early in infection and is then turned off at
late times via translational regulation (46, 47). However,
synthesis and accumulation of UL42 continues at late times,
leading to an excess of UL42 over that needed for a 1:1
complex with Pol (19, 36). This raises the possibility that the
free UL42 performs an additional function to the het-
erodimerized form, though it should be noted that a cell line
expressing approximately 1% of the normal levels of ULA2
efficiently complements the growth of a UL42 null virus (23).
The C-terminal 150 amino acids of UILA2 are apparently not
involved in increasing the processivity of Pol, so it is
tempting to speculate that this region of the protein may be
involved in such alternative functions. In support of this
idea, many of the counterparts of UL42 in other herpesvi-
ruses such as varicella-zoster virus (ORF 16), Epstein-Barr
virus (BMRF1), and cytomegalovirus (UI44) contain a
hydrophilic region at the C terminus that is similarly proline
rich in ORF 16 and BMRF1 and glycine-rich in UL44 (2, 7,
12, 15). Such conservation of structure is suggestive of a
functional role for the C-terminal domain. However, this
region of ULA2 is clearly not essential for virus replication in
Vero cells, as mutant AC340 complemented growth of a
UL42 null virus, albeit at less than wild-type efficiency
(Table 2). Therefore, if the C terminus of ULA2 does have a
function, it may be subtle or required in cells other than Vero
cells. Construction of a recombinant virus containing the
appropriately truncated UL42 gene should resolve this ques-
tion.
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